Correlation Between Kiromic Biopharma and Kodiak Sciences
Can any of the company-specific risk be diversified away by investing in both Kiromic Biopharma and Kodiak Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiromic Biopharma and Kodiak Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiromic Biopharma and Kodiak Sciences, you can compare the effects of market volatilities on Kiromic Biopharma and Kodiak Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiromic Biopharma with a short position of Kodiak Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiromic Biopharma and Kodiak Sciences.
Diversification Opportunities for Kiromic Biopharma and Kodiak Sciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Kiromic and Kodiak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Kiromic Biopharma and Kodiak Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kodiak Sciences and Kiromic Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiromic Biopharma are associated (or correlated) with Kodiak Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kodiak Sciences has no effect on the direction of Kiromic Biopharma i.e., Kiromic Biopharma and Kodiak Sciences go up and down completely randomly.
Pair Corralation between Kiromic Biopharma and Kodiak Sciences
If you would invest (100.00) in Kiromic Biopharma on November 9, 2024 and sell it today you would earn a total of 100.00 from holding Kiromic Biopharma or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Kiromic Biopharma vs. Kodiak Sciences
Performance |
| Timeline |
| Kiromic Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Kodiak Sciences |
Kiromic Biopharma and Kodiak Sciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiromic Biopharma and Kodiak Sciences
The main advantage of trading using opposite Kiromic Biopharma and Kodiak Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiromic Biopharma position performs unexpectedly, Kodiak Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kodiak Sciences will offset losses from the drop in Kodiak Sciences' long position.| Kiromic Biopharma vs. Quoin Pharmaceuticals Ltd | Kiromic Biopharma vs. Allarity Therapeutics | Kiromic Biopharma vs. Virax Biolabs Group | Kiromic Biopharma vs. Biodexa Pharmaceticals |
| Kodiak Sciences vs. Reviva Pharmaceuticals Holdings | Kodiak Sciences vs. Eyenovia | Kodiak Sciences vs. Cognition Therapeutics | Kodiak Sciences vs. Transcode Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |